A non-randomised open-label exploratory 'window of opportunity' study of TG02 treatment in patients with locally advanced primary and recurrent RAS mutant colorectal cancer
一项非随机、开放标签、探索性“机会窗口”研究,旨在评估TG02治疗局部晚期原发性和复发性RAS突变型结直肠癌患者的疗效。
期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e41364
Roth, Sara; Wilson, Kasmira Claire; Ramsay, Robert George; Mitchell, Catherine; Sampurno, Shienny; Pham, Toan Duc; Huei Kong, Joseph Cherng; Wong, Stephen Q; Heriot, Alexander Graham; Deva, Sanjeev; Burge, Matthew; Sverdrup, Cecilie; Moller, Anne-Sophie; Kuryk, Lukasz; Eriksen, Jon Amund; Jaderberg, Magnus; Zalcberg, John Raymond; Michael, Michael